0000950170-24-073122.txt : 20240613 0000950170-24-073122.hdr.sgml : 20240613 20240613170009 ACCESSION NUMBER: 0000950170-24-073122 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240611 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VEITINGER KLAUS R DR CENTRAL INDEX KEY: 0001283972 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38293 FILM NUMBER: 241042016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 BURLINGTON MALL ROAD, SUITE 203 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 25 BURLINGTON MALL ROAD, SUITE 203 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 ownership.xml 4 X0508 4 2024-06-11 0001604950 scPharmaceuticals Inc. SCPH 0001283972 VEITINGER KLAUS R DR C/O SCPHARMACEUTICALS INC 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 true false false false false Stock Option (Right to Buy) 4.11 2024-06-11 4 A false 19750 0.00 A 2034-06-11 Common Stock 19750 19750 D This stock option vests in full upon the earlier of (i) June 11, 2025, or (ii) the next annual meeting of the Issuer's stockholders. /s/ John H. Tucker, attorney-in-fact 2024-06-13